Imricor Medical Shares Surge on Fresh FDA Clearance
Highlights Imricor Medical Systems (ASX:IMR) shares surged after receiving an additional US Food and Drug Administration (FDA) clearance for its MRI-compatible cardiac catheter technology. The latest approval expands the device's use to include paediatric patients, broadening its addressable hospital market in the United States. Regulatory milestones continue to act as major catalysts for smaller ASX-listed medical technology companies. Shares in Imricor Medical Syst...



